Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.

Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.

The primary objective of this Collaborative Working Project (“CWP”) is to is to improve the quality and equity of care for patients and support the early identification, review, and medical ...

Novartis has been serving patients in Indonesia for more than 50 years, through our predecessor companies, Ciba and Sandoz.

Encontre vagas disponíveis na Novartis Brasil com base em seus interesses e habilidades.

Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search ...

MS ist individuell – die Behandlung sollte es auch sein Jede MS-Erkrankung verläuft anders. Deshalb sollte auch die Behandlung individuell angepasst werden. Ellen erklärt: „Meine MS ist einzigartig – ...

At Novartis, we celebrate life and recognize moments that matter. One of the most life changing moments our people experience is becoming a parent and welcoming new life into their lives. All Novartis ...

Leqvio can now be used alone, without addition of statin therapy, as adjunct to diet and exercise for LDL-C reduction in patients with hypercholesterolemia (high LDL-C) 1 4 out of 5 atherosclerotic ...

Oportunidades Laborales Explora oportunidades con Novartis a continuación. Para funciones adicionales con Novartis Gene Therapies (anteriormente AveXis), visita el siguiente link ...

Die hier zur Verfügung gestellten Informationen sollen eine sichere und effektive Anwendung von Zolgensma unterstützen. Sie sollen sicherstellen, dass Ärzte und Apotheker sowie Patienten die ...

• Scemblix® is first to show superior efficacy and a favourable safety and tolerability profile in a Phase III trial vs. all standard of care (SoC) therapies.1,2• Fifty percent of CML patients do not ...